Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 5:30 p.m.

    🌍 Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) - Form 6-K Filing

    Filing Date: 2022-06-14

    Accepted: 2022-06-14 06:17:36

    Event Type: Clinical Trial Update

    Event Details:

    Gracell also presented data on GC012F for treatment of B-NHL and allogeneic TruUCAR-candidate GC502. Management to host clinical update call on Monday, June 13, at 800AM ET. Gracell is a global clinical-stage biopharmaceutical company.

    💼 Business Developments:

    No specific business developments reported in this filing.

    📞 Contact Information:

    • Investor Contact: s Gracie Tong gracie.tong@gracellbio.com Stephanie Carrington stephanie.carringt
    • Media Contact: s Marvin Tang marvin.tang@gracellbio.com Kyle Evans kyle.evans@westwicke.com Inv
    • Email: marvin.tang@gracellbio.com

Search

News categories